Spots Global Cancer Trial Database for pheresis
Every month we try and update this database with for pheresis cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| CMV-MVA Triplex Vaccination in HLA-Matched Related Stem Cell Donors for the Prevention of CMV Infection in Patients Undergoing Hematopoietic Stem Cell Transplant | NCT06059391 | Acute Lymphobla... Acute Myeloid L... Chronic Lymphoc... Chronic Myeloid... Hematopoietic a... Hodgkin Lymphom... Myelodysplastic... Myelofibrosis Myeloproliferat... Non-Hodgkin Lym... | Allogeneic Hema... Biospecimen Col... Granulocyte Col... Hematopoietic C... Multi-peptide C... Pheresis Placebo Adminis... Stem Cell Mobil... | 18 Years - | City of Hope Medical Center | |
| A Study of FRaDCs for Ovarian Cancer | NCT05920798 | Fallopian Tube ... Primary Periton... Recurrent Fallo... Recurrent Fallo... Recurrent Fallo... Recurrent Fallo... Recurrent Ovari... Recurrent Ovari... Recurrent Ovari... Recurrent Ovari... Recurrent Ovari... Recurrent Prima... Recurrent Prima... Recurrent Prima... Recurrent Prima... | Biopsy Biospecimen Col... Computed Tomogr... Magnetic Resona... Multi-epitope F... Pembrolizumab Pheresis | 18 Years - | Mayo Clinic | |
| Dendritic Cell Therapy After Cryosurgery in Combination With Pembrolizumab in Treating Patients With Stage III-IV Melanoma That Cannot Be Remove by Surgery | NCT03325101 | Stage III Cutan... Stage IIIA Cuta... Stage IIIB Cuta... Stage IIIC Cuta... Stage IV Cutane... | Cryosurgery Pembrolizumab Pheresis Therapeutic Aut... | 18 Years - | Mayo Clinic | |
| Dendritic Cell Therapy After Cryosurgery in Combination With Pembrolizumab in Treating Patients With Stage III-IV Melanoma That Cannot Be Remove by Surgery | NCT03325101 | Stage III Cutan... Stage IIIA Cuta... Stage IIIB Cuta... Stage IIIC Cuta... Stage IV Cutane... | Cryosurgery Pembrolizumab Pheresis Therapeutic Aut... | 18 Years - | Mayo Clinic | |
| Dendritic Cell Vaccine Therapy With In Situ Maturation in Pediatric Brain Tumors | NCT01902771 | Glioma Brain Cancer Brain Tumor Glioblastoma Mu... High Grade Glio... | Dendritic Cell ... Tumor Lysate Imiquimod Leukapheresis | 1 Year - 29 Years | University of Miami | |
| Dendritic Cell Vaccine Therapy With In Situ Maturation in Pediatric Brain Tumors | NCT01902771 | Glioma Brain Cancer Brain Tumor Glioblastoma Mu... High Grade Glio... | Dendritic Cell ... Tumor Lysate Imiquimod Leukapheresis | 1 Year - 29 Years | University of Miami | |
| Lisocabtagene Maraleucel, Nivolumab and Ibrutinib for the Treatment of Richter's Transformation | NCT05672173 | Recurrent Trans... Refractory Tran... Richter Syndrom... | Biopsy Biospecimen Col... Bone Marrow Bio... Computed Tomogr... Cyclophosphamid... Fludarabine Ibrutinib Lisocabtagene M... Nivolumab Pheresis Positron Emissi... | 18 Years - | City of Hope Medical Center | |
| Modified Immune Cells (Autologous Dendritic Cells) and a Vaccine (Prevnar) After High-Dose External Beam Radiation Therapy in Treating Patients With Unresectable Liver Cancer | NCT03942328 | Stage III Hepat... Stage III Intra... Stage IV Hepato... Stage IV Intrah... Unresectable He... Unresectable In... | Atezolizumab Bevacizumab External Beam R... Pheresis Pneumococcal 13... Therapeutic Aut... | 18 Years - | Mayo Clinic | |
| Melphalan, Total Marrow Irradiation, and Autologous Stem Cell Transplantation in Treating Patients With High-Risk Multiple Myeloma | NCT03100877 | Plasma Cell Leu... Plasma Cell Mye... | Autologous Hema... Cyclophosphamid... Filgrastim Laboratory Biom... Lenalidomide pheresis Melphalan Palifermin Total Marrow Ir... | 18 Years - 70 Years | City of Hope Medical Center | |
| Dendritic Cell Therapy After Cryosurgery in Combination With Pembrolizumab in Treating Patients With Stage III-IV Melanoma That Cannot Be Remove by Surgery | NCT03325101 | Stage III Cutan... Stage IIIA Cuta... Stage IIIB Cuta... Stage IIIC Cuta... Stage IV Cutane... | Cryosurgery Pembrolizumab Pheresis Therapeutic Aut... | 18 Years - | Mayo Clinic | |
| External Beam Radiation With Intratumoral Injection of Dendritic Cells As Neo-Adjuvant Treatment for Sarcoma | NCT00365872 | Soft Tissue Sar... | Dendritic Cell ... Radiation thera... Complete Resect... | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute | |
| External Beam Radiation With Intratumoral Injection of Dendritic Cells As Neo-Adjuvant Treatment for Sarcoma | NCT00365872 | Soft Tissue Sar... | Dendritic Cell ... Radiation thera... Complete Resect... | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
